Sign In

Save up to 80% by drug discount in your pharmacy with "Pharmacy Near Me - National Drug Discount Card"

You can scan QR Code(just open camera on your phone/scan by application) from the image on prescription drug discount card to save it to your mobile phone. Or just click on image if you're on mobile phone.

View Generic:
View Brand:

Kocostar face therapy acne treatment cre am to pat ch - Medication Information

Product NDC Code 83888-020
Drug Name

Kocostar face therapy acne treatment cre am to pat ch

Type Brand
Active Ingredients
Salicylic acid .5 g/100ml
Route TOPICAL
Dosage Form LIQUID
RxCUI drug identifier 248684
Application Number M006
Labeler Name FIRSTMARKET CO., LTD.
Packages
Package NDC Code Description
83888-020-01 20 ml in 1 tube (83888-020-01)
Check if available Online

Active ingredient

A list of the active, medicinal ingredients in the drug product.
ACTIVE INGREDIENT Salicylic Acid 0.5%

Dosage and administration

Information about the drug product’s dosage and administration recommendations, including starting dose, dose range, titration regimens, and any other clinically sigificant information that affects dosing recommendations.
Directions clean the skin thoroughly before applying this productshake welcover the entire affected area with a thin layer using sterile cotton swablet it dry completely and leave in place for 8 hours to permit healingto remove, wet the area with warm water and gently roll with fingertips because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by doctorif bothersome dryness or peeling occurs, reduce application to once a day or every other day

Inactive ingredient

A list of inactive, non-medicinal ingredients in a drug product.
INACTIVE INGREDIENT Water, Cellulose, Niacinamide, Butylene Glycol, 1,2-Hexanediol, PEG-240/HDI Copolymer Bis-Decyltetradeceth-20 Ether, Caprylic/Capric Triglyceride, Hippophae Rhamnoides Oil, Butylene Glycol Dicaprylate/Dicaprate, Sulfur, Sorbeth-30 Tetraisostearate, Dipropylene Glycol, Sorbitan Sesquiisostearate, Acrylates/Beheneth-25 Methacrylate Copolymer, Tocopherol, Potassium Laurate, PPG-8-Ceteth-20, Capryloyl Salicylic Acid, Melaleuca Alternifolia (Tea Tree) Leaf Extract, Phenoxyethanol, Sodium Lauryl Sulfate, Ethylhexylglycerin, Sodium Benzoate

Indications and usage

A statement of each of the drug products indications for use, such as for the treatment, prevention, mitigation, cure, or diagnosis of a disease or condition, or of a manifestation of a recognized disease or condition, or for the relief of symptoms associated with a recognized disease or condition. This field may also describe any relevant limitations of use.
Uses for the treatment of acne clears acne blemishes and allows skin to heal helps prevent new acne blemishes from forming

Purpose

Information about the drug product’s indications for use.
PURPOSE Acne treatment

Spl product data elements

Usually a list of ingredients in a drug product.
KOCOSTAR FACE THERAPY ACNE TREATMENT CRE AM TO PAT CH Salicylic Acid 1,2-HEXANEDIOL NIACINAMIDE WATER BUTYLENE GLYCOL SALICYLIC ACID SALICYLIC ACID

Package label principal display panel

The content of the principal display panel of the product package, usually including the product’s name, dosage forms, and other key information about the drug product.
Carton Image

Keep out of reach of children

Information pertaining to whether the product should be kept out of the reach of children, and instructions about what to do in the case of accidental contact or ingestion, if appropriate.
KEEP OUT OF REACH OF CHILDREN If swallowed, get medical help or contact Poison Control Center right away.

Other safety information

Information about safe use and handling of the product that may not have been specified in another field.
Other Information store at room temperaturekeep away from heat or direct sunlightkeep lids tightly closeddo not dip used cotton swab into essence

Questions

A telephone number of a source to answer questions about a drug product. Sometimes available days and times are also noted.
Questions or comments www.kocostar.com / [email protected]

Warnings

Information about serious adverse reactions and potential safety hazards, including limitations in use imposed by those hazards and steps that should be taken if they occur.
WARNINGS For external use only. Do not use on broken skin. large areas of the skin When using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. Stop use and ask a doctor if irritation becomes severe. Avoid contact with eyes. If contact occurs, flush thoroughly with water.

Disclaimer: Do not rely on openFDA or Phanrmacy Near Me to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Source: OpenFDA, Healthporta Drugs API

Pharmacy Near Me® is not affiliated with or sponsored by any of pharmacies, pharmaceutical companies or other entities mentioned in its news articles, price comparisons, or press releases. All trademarks, copyright images, brands and logos are the property of their owners and right holders. They are used only for representing the products of the right holders. The information found at Pharmacy Near Me is for informational purposes only. It cannot be used as the substitute for professional medical advice. The information on this website is not meant to be used for self-treatment of self-diagnosis. Pharmacy Near Me is not endorsing or recommending any particular pharmaceutical product, pharmacy, pharmaceutical company, or any information on the site. Pharmacy Near Me provides no warranty for prescription drugs or other pharmaceuticals pricing data or other information related to these products. Please ask your doctor for a medical advice before starting, terminating or changing any medical treatment. The website is regularly updated with the latest information from multiple sources, including the Food and Drug Administration (FDA), NPPES NPI Registry, National Uniform Claim Committee (NUCC), Health Insurance companies, and the Centers for Medicare and Medicaid Services (CMS).